SMTL ID : 9ncv.1 (3 other biounits)

Crystal Structure of WDR5 in complex with Triazole-Based Inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.58 Å

Oligo State

monomer

Ligands

1 x 01: (6P)-6-[1-ethyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-3-[(4-fluoro-3-methylphenyl)methyl]-8-[(2-methyl-1H-imidazol-1-yl)methyl]-4,5-dihydro-3H-naphtho[1,2-d][1,2,3]triazole

01.1: 20 residues within 4Å: Chain A: A.137, V.138, S.139, A.155, G.179, I.180, S.181, D.182, D.197, F.223, F.239, P.263, Y.281, K.349, Y.350, C.351, I.352, F.353, I.395, L.411 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:F.239, A:P.263, A:Y.281, A:F.353, A:I.395, A:I.395 Hydrogen bonds: A:Y.281, A:C.351 pi-Stacking: A:F.223, A:F.223, A:Y.350, A:F.353 Halogen bonds: A:V.138

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Coker, J.A. et al., Development and Characterization of Triazole-Based WDR5 Inhibitors for the Treatment of Glioblastoma. Biorxiv (2025)

Release Date

2025-08-13

Peptides

WD repeat-containing protein 5: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

WD repeat-containing protein 5

Related Entries With Identical Sequence